This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
WARNINGS AND PRECAUTIONS: Intussusception
In a postmarketing, observational study conducted in Mexico, cases of intussusception were observed in temporal association within 31 days following the first dose of Rotarix, with a clustering of cases in the first 7 days. ADVERSE REACTIONS: Postmarketing experience includes the temporal association between vaccination with Rotarix and intussusception was evaluated in a hospital-based active surveillance study that identified infants with intussusception at participating hospitals in Mexico. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm230397.htm (continued)
